LncRNAs	Disease	Experimental methods	Regulated											Pubmed ID	Year
ZFPM2-AS1	esophageal squamous cell carcinoma	qRT-PCR, Western blot	H	✘	✘	✘	✘	✘	✘	✔	✘	✔	✘	32065218	2020
ZFPM2-AS1	gastric cancer	qPCR, Western blot, in vitro knockdown, RIP	H	✘	✘	✔	✘	✘	✘	✔	✘	✔	✘	29985481	2018
ZFPM2-AS1	lung adenocarcinoma	qRT-PCR, Luciferase reporter assay, RIP, Western blot	H	✘	✘	✘	✘	✘	✘	✔	✔	✘	✘	31919993	2020
ZFPM2-AS1	lung adenocarcinoma	qRT-PCR, Western blot analysis, Luciferase reporter assay, RIP	H	✘	✘	✘	✘	✔	✘	✔	✔	✘	✘	31692047	2020
ZFPM2-AS1	renal cell carcinoma	qPCR, Luciferase reporter assay, RIP	H	✘	✘	✔	✘	✔	✘	✔	✘	✔	✘	31298319	2019
ZFPM2-AS1	lung adenocarcinoma	qPCR, Western blot, Luciferase reporter assay, RIP	H	✘	✘	✔	✘	✘	✘	✔	✘	✘	✘	31297866	2019
ZFPM2-AS1	gastric cancer	qRT-PCR, Western blot assays, RNA pull-down assay, RIP	H	✘	✘	✔	✘	✘	✘	✘	✘	✘	✘	29985481	2018
ZFPM2-AS1	Hepatocellular carcinoma	qRT-PCR,Western blot,Luciferase reporter assay,FISH etc.	L	✘	✘	✘	✘	✘	✘	✔	✘	✘	✘	32744687	2020
ZFPM2-AS1	Thyroid cancer	ChIP;ELISA;Chromatin immunoprecipitation;Luciferase reporter assay;	L	✘	✘	✘	✘	✘	✘	✔	✘	✘	✘	33976749	2021
ZFPM2-AS1	Melanoma	qPCR;RT-qPCR;RNA immunoprecipitation;Flow Cytometry assay;RNA immunoprecipitation;	L	✘	✘	✘	✘	✘	✘	✔	✘	✘	✘	33406278	2021